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Dietary polyphenols in tea and wine have been associated with beneficial health effects. After
ingestion, most polyphenols are metabolized by the colonic microbiota. The current study aimed at
exploring the interindividual variation of gut microbial polyphenol bioconversion from 10 healthy human
subjects. In vitro fecal batch fermentations simulating conditions in the distal colon were performed
using polyphenols from black tea and a mixture of red wine and grape juice. Microbial bioconversion
was monitored by NMR- and GC-MS-based profiling of diverse metabolites and phenolics. The
complex polyphenol mixtures were degraded to a limited number of key metabolites. Each subject
displayed a specific metabolite profile differing in composition and time courses as well as levels of
these metabolites. Moreover, clear differences depending on the polyphenol sources were observed.
In conclusion, varying metabolite pathways among individuals result in different metabolome profiles
and therefore related health effects are hypothesized to differ between subjects.
KEYWORDS: Fecal batch fermentations; gut microbiota; interindividual variation; metabolomics;
tea/wine polyphenols
INTRODUCTION
Epidemiologic data as well as experimental studies suggest
health benefits for dietary polyphenols that are abundantly
present in foods such as tea and wine (1). Polyphenols that are
initially absorbed in the ileum can subsequently be excreted as
conjugates in the bile and pass through the small intestine before
they arrive in the colon.However, amajor portion of nonabsorbed
polyphenols reaches the colon directly after gastrointestinal
passage (2), where they can be deconjugated and fermented by the
gut microbiota to a wide range of low-molecular-weight meta-
bolites, which may be absorbed by the host (3).
Themicrobial community in the human colon is highly diverse:
it comprises 1012 bacteria/g of colonic content belonging to
hundreds of different species and exerts a profound impact on
human health (4,5). The composition of the gutmicrobiota varies
substantially among individuals (6). Consequently, each intest-
inal microbial community can be expected to display its own
characteristic metabolic profile. It has been reported that parti-
cular beneficial effects of polyphenol-rich foods are dependent
on biotransformation by intestinal bacteria to bioactive meta-
bolites (7). For some polyphenolic compounds, bioconversion
has been shown to vary between individual persons due to differences
in the metabolic potential of their endogenous microbiota (8).
However, the underlying mechanisms and bacterial species in-
volved in polyphenol breakdown have not yet been identified
sufficiently (for review see ref3), and the bacterial metabolism of
complex mixtures of polyphenolic substances as present in the
human diet has been studied far less extensively than that of single
compounds. For instance, black tea and red wine/grape poly-
phenol extracts are complex mixtures with only partially known
composition. Basically, red wine polyphenols mainly contain
proanthocyanidins, anthocyanins, catechins, flavonols, and some
phenolic acids, whereas black tea polyphenols are primarily
composed of thearubigins, theaflavins, catechins, flavonols, and
phenolic acids (9, 10).
A detailed overviewof bacterial polyphenolmetabolites gained
with metabolomics technologies can increase our understanding
of the bioconversion of dietary compounds by the intestinal
microbiota and would contribute to unravelling the mechanisms
of beneficial health effects associated with dietary polyphenols.
To this end, in vitro batch fermentations were performed inwhich
fecal samples from 10 human volunteers were incubated with
polyphenol extracts from black tea and amixture of red wine and
grape juice (henceforth called wine/grape extract), respectively.
Culture models of human colonic microbiota that simulate
microbial processes in the large intestine have proven to be useful
tools to investigate the extensive microbial metabolism of natural
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polyphenols (11). In contrast to more sophisticated, but time-
consuming in vitro gut models, batch fermentations provide a
feasible possibility to assess multiple experimental conditions by
using fecal samples from several subjects (12). Therefore, they
allow comparison of microbial fermentation processes of differ-
ent human microbial communities under simulated conditions as
present in the distal colon by using metabolite profiling meth-
ods (13). The wide range of bacterial breakdown products was
monitored over time using two metabolite profiling techniques.
Nuclear magnetic resonance (NMR)-based metabolite profiling,
a fast and broad, but rather insensitive profiling technique, was
employed to detect changes of the major degradation products,
including some phenolic metabolites and short chain fatty acids
(SCFAs). In addition, a more sensitive technique, gas chromato-
graphy-mass spectrometry (GC-MS)-based profiling of pheno-
lics, was used to focus on this specific compound class. Both
techniques have been recently established for human intestinal
samples in our laboratory (14, 15). With these combined meth-
ods, key metabolites were identified and the interindividual
variability between microbial metabolic pathways of poly-
phenols from tea and wine/grape was characterized.
MATERIALS AND METHODS
Batch Culture Fermentations. In vitro fermentation experiments
were performed under conditions as used in previous studies (8,16). Fresh
fecal samples were obtained from 10 healthy free-living volunteers with no
dietary restrictions (six female, four male; aged 25-34 years; Caucasian,
no recent history of gastrointestinal disease). The samples were trans-
ported under aerobic conditions and further processed to anaerobic
conditions within maximum 1 h, in most cases within a few minutes.
For this, 20 g of the fecal matter was homogenized with a stomacher in
100 mL of phosphate buffer containing sodium thioglycolate as reducing
agent. The particulate material was removed by brief centrifugation. The
experiments were performed in serum bottles containing 44.5mL of sterile
basal medium (17) with doubled amounts of NaHCO3, K2HPO4, and
KH2PO4 to enhance buffering capacity. Prior to addition of 5 mL of the
fecal slurries (or phosphate buffer as a control), the bottles were sealed
with rubber tops, and anaerobiosis was obtained by flushing with N2
during 20 cycles of 2 min at 700 mbar overpressure and 900 mbar under
pressure. After addition of 0.5 mL of dissolved polyphenol extracts or
distilled water as control (referred to as “blank experiment”), the suspen-
sions were mixed by shaking and incubated at 37 !C for 72 h, with
sampling at baseline (0 h) and after 2, 4, 8, 24, 32, 48, and 72 h. Samples
were collected using syringes and stored at-80 !C within 5 min in closed
tubes. Samples were kept frozen at all times prior to the use of 0.5 mL
aliquots for NMR and GC-MS analysis. The pH of the samples was
measured at time points 0, 8, 24, 32, 48, and 72 h.
Two different polyphenol sources, a mixture of wine and grape juice
extract and a black tea extract, were used. The wine/grape extract was
composed of two parts of red wine extract Provinols (Seppic, France) and
one part of MegaNatural Rubired grape juice extract (Polyphenolics,
USA). The tea extract was prepared by spray-drying from Lipton Yellow
label black tea (Unilever, The Netherlands). The wine/grape extract and
tea extract were taken from single batches and contained 57% and 32%
total polyphenols, respectively. Stock solutions were prepared by dissol-
ving 1762.5 mg wine/grape extract powder and 3125.0 mg tea extract
powder in 10 mL of distilled water, respectively, and additionally diluted
1:2 with distilled water to obtain lower concentrations. These solutions
were stored at 4 !C until further use. In the experiments, 0.5 mL of the
stock solution were added to obtain a total volume of 50 mL in the
penicillin flasks, yielding final polyphenol concentrations of 500 and 1000
mg/L, respectively. Comparable concentrations have been used in pre-
vious experiments (17, 18), aiming at simulation of physiological condi-
tions because the total dietary polyphenol intake for humans has been
estimated to be approximately 1 g per day (19).
NMRAnalysis.The thawed samples were centrifuged (5 min, 22000g,
8 !C). NMR samples were prepared by adding 50 μL of deuterium oxide
(D2O) containing 10 mM deuterated sodium trimethylsilyl propionate
(d-TSP) to 450 μL supernatant. D2O and d-TSP serve as field frequency
lock and chemical shift reference, respectively.
One-dimensional (1D) high-resolution 1HNMR spectra were acquired
on a Bruker Avance 600 NMR spectrometer operating at a proton NMR
frequency of 600.13 MHz and at a temperature of 300 K. A 5 mm TXI
probe and a sample changer for sample delivery were used. A noesypresat
pulse sequence with 32k data points and 64 scans over 8993 Hz was used.
Water suppression was achieved during the relaxation delay (3 s) and the
mixing time (150 ms). The spectra were manually corrected for phase and
baseline distortions using Topspin 1.3 software (Bruker Analytik, Rhein-
stetten, Germany). An exponential window function with a line-broad-
ening factor of 0.3 Hz was applied to the free induction decay (FID) prior
to Fourier transformation. The spectra were referenced to TSP (δCH3:
0 ppm). Metabolites were identified using an in-house database and a
database (bbiorefcode-2-0-0 implemented in Amix 3.7.3., Bruker Biospin
GmbH, Germany) including reference spectra of metabolites at different
pH values. Metabolites were quantified using Chenomx NMR Suite 5.1.
(Chenomx Inc., Edmonton, Canada). Assignment of signals was mainly
performed as described previously (14).
GC-MS Analysis. The production of phenolic acids was profiled
usingGC-MS as described earlier (15). In particular, 0.4mL of the thawed
samples were first centrifuged at 22000g for 5min at 8 !C.T-cinnamic acid-
d6 (100 μg/mL in 1:1 methanol/water (v/v)) was added as internal
standard. The solutions were acidified with 2 M HCl and stored at 4 !C
for 10 min. Subsequently, 2 mLof ethyl acetate were added and the tubes
were vortex-mixed for 30 s, followed by centrifugation at 3000g for 10 min.
The supernatants were transferred, and the extraction was repeated twice.
Extracts were combined and dried under a stream of nitrogen using a
heating block at 40 !C. Further drying was performed by subsequent
addition and evaporation of 1 mL of dichloromethane. The dry samples
were derivatized with 100 μL of N,O-bis(trimethylsilyl)trifluoroacetamide
(BSTFA) þ 10% trimethylchlorosilane (TMCS) for 30 min at 90 !C. After
derivatization, 400 μL of n-hexane were added to the samples and after
vortex-mixing, 200 μLwere transferred toGC vials for analysis byGC-MS.
The calibration standards were prepared from a phenolic acid stock
solution containing 33 phenolic acids (Table S1, Supporting Information)
at a concentration of 100 μg/mL. The stock solution was diluted with a 1:1
methanol/water (v/v) solution to the desired concentration using the
following dilution factors: 10, 20, 100, 200, 500, 1000, 2000, 5000, 10000.
For each calibration series, 50 μL of the respective standard plus the
internal standard at a concentration of 5 μg/mL were dried under a
stream of liquid nitrogen and further dried using two times 1 mL of
dichloromethane. Further processingwasperformed in the sameway as the
experimental samples.
Derivatized samples were analyzed with a time-of-flight mass analyzer
(Waters Micro Mass GCT accurate mass spectrometer) interfaced with
an Agilent 6890 gas chromatograph and with a Hewlett-Packard 7683
autosampler. The injection port was kept at 55 !C for 1 min and then
increased to 300 at 10 !C/s. TheMS source and theGC-MS interface were
kept at 180 and 250 !C, respectively. Separations were carried out on a
Varian Factor Four fused silica capillary column (30 m " 0.25 mm i.d.)
coated with cross-linked 5% phenyl methyl dimethylpolysiloxane (film
thickness 0.1 μm). Helium was the carrier gas with a constant flow of
1 mL/min. Derivatized samples (1 μL, using a 5 μL syringe) were injected
into the GC injection port using a split ratio of 1:10. The column temp-
erature was kept at 45 !C for 1 min, then increased from 45 to 100 !C at
10 !C/min, then from 100 !C to 250 at 7.5 !C/min, then from 250 to 300 !C
at 20 !C/min, where it was held for 6min. Full scanningmass spectrometry
was applied for all analysis using the electron-ionization (EI) mode at
70 eV. For calibration, the phenolic acid standard mixture was analyzed
with each sample set or once per week, as applicable.
Statistical Analysis.Mean values, standard deviations, and coefficient
of variations (CV = SD/mean) were calculated from the total amount of
variability metabolites produced within 48 h (AUC in mM 3 h) of fermenta-
tions with tea and wine/grape extract, respectively. To estimate the inter-
individual variation in the metabolite production from fermentations with
tea andwine/grape extract, respectively, correlationmatrices (Pearson) were
calculated onAUCvalues and scaled tounivariance andusing a significance
level of p< 0.01.
Box plots including median, minimum, maximum, 25th quartile, and
75th quartile values were calculated for the concentrations of several
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SCFAs as determined from fermentation experiments using 1000 mg/L
polyphenols after 72 h. An ANOVA test was performed to assess statisti-
cally significant effects for each of the SCFAs.
RESULTS
CombinedMetabolite ProfilingMethods Provide Comprehensive
Information on Microbial Polyphenol Bioconversion under Batch
Fermentation Conditions. In vitro batch culture fermentations
were performed using colonic microbiota from 10 healthy volun-
teers. With each fecal sample, five batch fermentations were
performed with either the wine/grape or tea extract added at a
concentration of 500 and 1000 mg/L, respectively, or water as a
negative control. pHmeasurements at regular time points revealed
amaximumaverage decrease in pHamong the different treatments
of 0.46 units between time point 0 h and 72 h, demonstrating that
the pH remained relatively stable throughout the incubation
(average of all treatments ( standard deviation: pH 7.15 ( 0.07
at 0 h; pH 6.92 ( 0.26 at 72 h).
Supernatants of all batch fermentations were analyzed using
NMR-based metabolite profiling. The complex NMR profiles
comprised different classes of compounds such asmajor phenolic
acids, SCFAs, alcohols, and amines. The profiles generated from
incubations with 1000 mg/L polyphenols were generally used to
quantify the major phenolic metabolites due to their higher
signal-to-noise-ratios. Figure S1 of Supporting Information illus-
trates how the bioconversion of polyphenols could be traced with
this method over a period of time using signals originating from
initial substances, intermediate and end products, and invariant
compounds. However, the profiles obtained from the blank
experiments showed that nutrients from the medium were con-
sumed over time and converted to intermediate products, such as
ethanol and lactate, and end products, mainly SCFAs, phenyl-
acetic acid, and3-phenylpropionic acid (datanot shown).Therefore,
the values obtained from the incubation with the polyphenol
extracts were corrected for the corresponding blank values,
resulting in metabolite changes that can be solely attributed to
polyphenol bioconversion. Separate incubations of the medium
with polyphenol extracts but without fecal inoculum served as
additional controls and confirmed that the signals did not arise
from nonmicrobial degradation processes (data not shown).
In comparison toNMR-basedmetabolite profiling, GC-MS is
a more sensitive method. Therefore, samples originating from
incubations with the lower initial ingredient concentration of 500
mg/mL were analyzed with this method. The recorded GC-MS
profiles included numerous phenolic metabolites, and changes in
the levels of less abundant phenolicacids such asdiverse derivatives
Figure 1. Conversion of free gallic acid and conjugated gallic acid in epigallocatechingallate (EGCG) and other gallo-tannins potentially present in black tea
extract (3 , 20) (left lower panel) to pyrogallol (right lower panel; both derived from 1H NMR spectra). The kinetic curves from each subject are displayed by
different colors. The concentration derived from the blank experiment was subtracted from the concentration derived from the experiments using the tea extract
(conc (tea-blank)/mM).
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of hydroxyphenylacetic acids and hydroxybenzoic acids were
detected.
The two measurement approaches NMR and GC-MS com-
plemented each other. Low abundant phenolic acids were only
detectable by GC-MS, and highly abundant phenolic acids that
were within the saturation limit of GC-MS were determined by
NMR spectroscopy.
The Concentration of the Polyphenol Source Has a Limited
Impact on the Metabolite Profile. The metabolite profiles from
incubations with 500 and 1000 mg/L polyphenol extract were
comparable with respect to the metabolites produced and their
time courses. For example, similar time courses were obtained for
the production of 3-(4-hydroxyphenyl)propionic acid after incu-
bationswith 500 and 1000mg/Lof the tea andwine/grape extract,
respectively (Figure S2, Supporting Information). Slight differ-
ences in the production of 3-(4-hydroxyphenyl)propionic acid can
be attributed to the different polyphenol concentrations used. For
example, whereas 3-(4-hydroxyphenyl)propionic acid was found
to be only temporarily produced by the microbiota of subject 9
when 500 mg/L of the tea extract was incubated, it was still
detectable after 72 h of fermentation with 1000 mg/L of the same
extract. This result demonstrates that the initial concentrations
only had a minor impact on the metabolite profiles and that the
incubations were generally reproducible. Only the production
of pyrogallol from gallic acid present in free form or in larger
polyphenols such as epigallocatechingallate in the tea extract (20)
strongly depended on the initial concentration and was only
observed in incubations with 1000 mg/L black tea extract. Pyro-
gallol was not quantitatively converted from gallic acid and further
degraded by the microbiota of most subjects except for subject 7,
for whom it was still detectable after 72 h (Figure 1).
Polyphenol Bioconversion by Human Gut Microbiota Is Char-
acterized by Strong Interindividual Variations. Table 1 and Figure
S3 of Supporting Information provide an overview of the diversity
of metabolite changes observed by NMR- and GC-MS-based
metabolite profiling, illustrating that each individual was charac-
terized by a specificmetabolite profile differing in composition and
time courses as well as levels of the metabolites produced. Some
metabolites such as 3-hydroxybenzoic acid and 3,5-dihydroxy-
benzoic acid were only detected in incubations of samples from a
few subjects. Other metabolites varied significantly in the levels
produced and their appearance over time as shown by the
coefficients of variations (CV) ranging between 39 and 265%
(average CV = 0.91) (Figure S3 of Supporting Information) and
the individual kinetic curves for several metabolites provided in
Figures 1-3 and in the Supporting Information (Figure S4 of
Supporting Information), respectively. Principal component ana-
lysis (PCA) revealed no clustering of groups (data not shown) and
no (except one) significant correlations of the AUC values of
various metabolites between the subjects were found (Figure S3
of Supporting Information), showing that the metabolite profiles
differ between subjects. A central example demonstrating the
interindividual variability of polyphenol bioconversion is the
production of 3-phenylpropionic acid and its hydroxylated deri-
vatives (Figure 2). 3-Phenylpropionic acid is a typical end meta-
bolite thatwas produced formost subjects except for subjects 6 and
9 who did not produce or even produced lower levels of 3-phenyl-
propionic acid as compared to blank conditions. Similarly, 3-(3-
hydroxyphenyl)propionic acid was detected as an end metabolite
although in lower amounts. In contrast, 3-(4-hydroxyphenyl)pro-
pionic acidwas only temporarily produced formost subjects except
for subjects 6, 7, and 9, for which this metabolite was still present
after 72 hof fermentation.The temporary runs of the kinetic curves
from subject 3 suggest the conversion from 3-(4-hydroxyphenyl)-
propionic acid and 3-(3-hydroxyphenyl)propionic acid to 3-(phenyl)-
propionic acid. For other subjects, this conversion may be less
efficient or even inhibited as for subjects 6 and 9, who did not
produce 3-phenylpropionic acid.
DifferentMetabolites Are Formed from Black Tea or RedWine/
Grape Polyphenols by Human Gut Microbiota. Clear differences
Table 1. Overview of Metabolite Changes from the Fermentations with Black Tea and Red Wine/Grape Juice Extracts with Respect to Blank Experiments Derived
from 1H NMR (Indicated by NMR) and GC-MS Profilesa
aColor coding indicates time point of maximum reduced or increased value occurrence (reduced: dark-blue squares: 72 h; light-blue squares: 24 h; increased: light-yellow
squares: 0/2 h; medium-yellow squares: 4 h; dark-yellow squares: 8 h; light-orange squares: 24 h; dark-orange squares: 32 h; red squares: 48/72 h; n/a: not applicable; *: present in
initial extract).
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wereobservedbetween themicrobialmetabolites thatwere produced
from the black tea and redwine/grape polyphenols, respectively. For
instance, the metabolites pyrogallol and gallic acid were exclusively
found for the fermentation of black tea polyphenols (Figure 1), with
gallic acid already being present in the initial tea extract. Further-
more, vanillic acid was hardly detected in samples incubated with
black tea polyphenols, whereas this compound was present in small
amounts in the initial red wine/grape extract and clearly produced
as an intermediate metabolite from the wine/grape polyphenols
(Figure 3). On the contrary, 2,6-dihydroxybenzoic acid was exclusi-
vely present after incubation with black tea extract (Table 1).
The differences between the conversion of black tea and red
wine/grape polyphenols were not only reflected in the produc-
tion of different metabolites but also in the produced levels.
For example, on average, higher levels of 3-(3-hydroxyphenyl-
propionic acid) were produced from the wine/grape extract than
from the tea extract, whereas the opposite was found for the
production of 3-hydroxyphenylacetic acid (Figure 3).
The Complex Polyphenol Mixtures Are Converted to a Limited
Number of Key Metabolites by Human Gut Microbiota. The poly-
phenol extracts used in the present study are complexmixtures the
compositions ofwhichwere only known to a limited extent due to
Figure 2. Bioconversion of 3-(3-hydroxyphenyl)propionic acid (left panel) and 3-(4-hydroxyphenyl)propionic acid (right panel) to 3-phenylpropionic acid
(middle panel) from wine/grape extract as derived from 1H NMR spectra and initial concentrations of 1000 mg/L. The kinetic curves from each subject are
displayed by different colors. The concentration derived from the blank experiment was subtracted from the concentration derived from the experiments using
the wine/grape extract (conc (wine-blank)/mM).
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analytical obstacles to identify oligomeric polyphenols. For
example, only 20-30% of the compositions of the red wine and
grape juice extracts compositions were identified by liquid
chromatography using commercially available standards. The
major fraction consistedofoligomericproanthocyanidins. Similarly,
the major fraction of flavonoids in the black tea extract included
unidentified thearubigines. The phenolic components that were
quantified in the tea and wine/grape extract are listed in Table S2
of Supporting Information.
These complex mixtures were converted to a variety, but still
limited number of metabolites summarized inTable 1. The major
metabolites producedwere 3-phenylpropionic acid and its hydro-
xylated derivatives followed by phenylacetic acid and its hydro-
xylated derivatives. Benzoic acids were generally produced in
lower amounts. This result indicates that diverse polyphenols
were funnelled to a set of key metabolites potentially by using
similar polyphenol bioconversion pathways.
Incubation with Polyphenols Has an Impact on Bacterial Pro-
duction of SCFAs. Several SCFAs were quantified from NMR-
based metabolite profiles (Figure 5). The levels of acetic acid
were significantly increased upon fermentation with black tea
polyphenols and to a lesser extent after incubation with the
wine/grape extract. Butyric acid concentrations tended to
increase after fermentation with both polyphenol extracts.
The levels of propionic acid did not change during the
fermentations with polyphenols. In contrast, isobutyric acid
and isovaleric acid tended to decrease after fermentation with
the tea extract.
Figure 3. Differences in the bioconversion of black tea (left panels) and wine/grape polyphenols (right panels) as observed for 3-(3-hydroxyphenyl)propionic
acid as determined by 1H NMR (A), vanillic acid (B), and 3-hydroxyphenylacetic acid (C), as determined by and GC-MS. The kinetic curves from each subject
are displayed by different colors. The concentration derived from the blank experiment was subtracted from the concentration derived from the experiments
using the wine and tea extracts, respectively (conc (wine-blank); (conc (wine-blank)/mM; conc (tea-blank)/mM).
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DISCUSSION
In the current study, batch culture fermentations on fecal
samples from 10 healthy individuals were performed to assess
the interindividual variability of polyphenol metabolism by gut
microbiota and to compare the microbial bioconversion of red
wine/grape and black tea polyphenols. Most importantly, sub-
stantial interindividual differences in the production of numerous
bacterial polyphenol metabolites were observed. This interindi-
vidual variability was characterized by the production of different
metabolites, by different levels of the intermediate and end
products as well as by variable time courses, suggesting that each
individual generates a specific microbial metabolome. This may
be attributed to different bacterial populations present in the
individual fecal microbial communities, harboring specific enzy-
matic capacities and therefore reflect microbial diversity among
individuals (21). In agreement with this, each individual fecal
sample was characterized by a distinct microbial composition
(R< 0.32, average CV= 0.69) as determined by HITChip ana-
lysis, an oligonucleotide microarray for phylogentic profiling of
human intestinal tract communities (22) (Tables S3, S4 of Sup-
porting Information).
Besides the diversity of the gut microbes and their complex
interplay, individual dietary habits may have caused slightly
varying levels of initial polyphenol concentrations and thus slight
differences in the metabolite production.
The interindividual variability in the production ofmetabolites
might also be due to several cleavage possibilities. For example,
quercetin or quercetin-3-rutinoside present in black tea (23) can
be broken down to 3-hydroxyphenylacetic acid, 3-(3-hydroxy-
phenyl)propionic acid, and 3,4-dihydroxbenzoic acid (17, 24). In
general, 3-(3-hydroxyphenyl)propionic acid was predominantly
produced, whereas 3-hydroxybenzoic acid was only marginally
present, indicating that β-oxidation was not a major bacterial
degradation route. This is in line with earlier indications that
β-oxidation of dietary flavonoids only occurs in host tissues (25).
In vivo, 3-phenylpropionic acid is known to be absorbed by the
host, usually converted to benzoic acid, conjugated with glycine
to hippuric acid that is finally excreted in urine (26). In compar-
ison, hydroxylated phenylacetic acids are not further metabolized
after absorption or methylated in the liver before their urinary
excretion (23).
Furthermore, different kinetics of the polyphenol degradation
may contribute to the interindividual variability in the metabolite
profiles. For instance, fast or inhibited conversion of 3-(4-hydro-
xyphenyl)propionic acid to 3-phenylpropionic acid (Figure 2) was
observed, which is in line with previous studies indicating dif-
ferences in the ability of the intestinal microbiota of individual
rats and humans to dehydroxylate 3-(4-hydroxyphenyl)propionic
acid to 3-phenylpropionic acid with a corresponding impact on
the urinary excretion of downstream metabolites (26, 27). Also
the conversion from 3-(3-hydroxyphenyl)propionic acid to 3-phenyl-
propionic acid, which has been described earlier in literature
(17, 28), was more or less efficient potentially depending on the
individual microbiota composition. Another example for different
conversion rates is the degradation from gallic acid to pyrogallol,
which is known to be absorbed by the host and further excreted as
pyrogallol sulfate in urine in vivo (29). In the present in vitro study,
however, pyrogallol was further degraded potentially via pholor-
glucinol to butyrate and acetate (30). Because the temporary
production of pyrogallol was only observed at the high initial
concentration of black tea extract, the degradation of gallic acid
is most likely a fast process. Similarly, phloroglucinol was not
detected in samples from all individuals (Figure S4 of Supporting
Information) and hence may indicate a highly efficient conversion
rather than a reduced production of this compound, as phloro-
glucinol is known to be rapidly degraded by intestinal bacterial
species (31).
Interestingly, the wine/grape and tea extracts with their com-
plex polyphenol compositions were fermented to a limited num-
ber of key metabolites, in particular to 3-phenylpropionic acid
and its hydroxylated derivatives. This observation indicates a
funnel process using common degradation pathways for diverse
polyphenols and is in line with other findings on dietary fibers,
suggesting that different bacterial colonic communities share
general biochemical characteristics metabolizing different sub-
strates to specific metabolic patterns (32). The funnel process is
illustrated in Figure 4, displaying the total amounts of diverse
metabolites produced per individual and extract as well as
conversion steps from several polyphenols known to be present
in the extracts. For example, various polyphenols such as caffeic
acid and catechin are known to be degraded to 3-(3,4-dihydroxy-
phenyl)propionic acid which can be further dehydroxylated
to 3-(3-hydroxyphenyl)propionic acid and finally to 3-phenyl-
propionic acid (17, 33, 34). Another example is 3,4 dihydroxy-
phenylacetic acid, which is known to be a degradation product
from quercetin and procyanidin (dimer) (23, 35). Furthermore,
3-(4-hydroxyphenyl)propionic acid can originate from p-couma-
ric acid and catechin, while 3,4-dihydroxybenzoic acid is a known
metabolite from anthocyanidins, catechin, and quercetin
(17,36,37). The funnel process also became apparent in the total
amount of metabolites produced within 72 h. For example, in
most cases higher amounts of 3-(4-hydroxyphenyl)propionic acid
were generated than the initial amount ofp-coumaric acid present
in the tea extract, indicating that 3-(4-hydroxyphenyl)propionic
acid was also produced from other precursors. This funnel pro-
cess may enhance the interindividual variability in the metabolite
production and hamper the prediction ofmetabolite profiles from
complex polyphenol mixtures. On the other hand, structurally
closely related compounds present both in the tea and wine/grape
extracts may also partly explain why microbial bioconversion of
the different polyphenol sources resulted in the formation of
typical central end products. For instance, the basic building
blocks of larger proanthocyanidins and thearubigins (poly-
merized theaflavins) are catechins, which are concatenated in
a different manner and to a different degree (38).
Despite the interindividual differences, both polyphenol ex-
tracts were clearly distinguishable in their metabolite profiles,
demonstrating that bioconversion also depended on the pre-
cursor substances. For example, the formation of pyrogallol and
2,6-dihydroxybenzoic acid could be primarily ascribed to poly-
phenols from black tea, whereas vanillic acid was only detected in
profiles of samples incubated with the wine/grape extract. More-
over, the amounts of specific metabolites such as 3-(3-hydroxy-
phenyl)propionic acid varied between the two polyphenol
extracts. This variation can be attributed to the different compo-
sition of the two polyphenol extracts and is in agreement with
previous reports on variousmicrobial metabolites produced from
tea or wine polyphenols such as proanthocyanidins, catechins,
and tea flavonoids (33). Considering that the conversion of
diverse polyphenols after ingestion generates a limited number
of key metabolites that potentially exert health benefits on the
host rather than the initial compounds, future studies are recom-
mended to focus on exploring the downstream effects of these
metabolites on the host.
In addition to the formation of phenolics, the incubation with
especially black tea extract resulted in significantly elevated levels of
acetate anda slight increase in theproductionof butyrate (Figure 5).
The latter may be of interest due to beneficial health effects that
have been associated with butyrate production in the colon (39).
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Furthermore, the levels of branched-chain fatty acids such
as isovalerate and isobutyrate tended to be reduced after
fermentation of the black tea extract (Figure 5). The decreased
production of isobutyrate is in line with earlier in vivo results
from human volunteers who received the same wine/grape
extract (14 ). The effects on the production of SCFAs may be
caused by the degradation of the polyphenols. For example,
butyrate has been identified earlier to be produced from
quercetin and other flavonoids by microorganisms isolated
from human feces (18 , 24 ) and from catechin and tannic
acid after batch fermentations with rat cecal inoculum (40 ).
Furthermore, sugar moieties typically conjugated to poly-
phenols in plant material (the polyphenol extracts were not
pre-digested before the fermentations) and other non-phe-
nolic substances present in the tea and wine/grape extracts
are likely to have contributed to the observed effects on
SCFAs.
In this study, the combination of NMR- and GC-MS-based
profiling technologies provided a strong methodological advan-
tage, allowing the detection of a wide range of polyphenol meta-
bolites in order to gain comprehensive insight into the complex
colonic metabolism of polyphenols. Our data suggest that the
Figure 4. Illustration of the funnel process indicating the bioconversion of several polyphenols present in the tea and/or wine/grape extracts, such as quercetin,
procyanidin (dimer), catechin, anthocyanin, caffeic acid, and p-coumaric acid to a variety of phenolic acids detected by 1H NMR and GC-MS. The arrows
indicate cleavage possibilities of different polyphenols. In the smaller diagrams, the total amounts of metabolites (AUC in mM 3 h) produced within 48 h of
fermentation of 500 mg/L polyphenol extract are plotted for the tea and wine/grape extracts, respectively, and for each individual as indicated by different
symbols. (4-OH-benzoic acid: 4-hydroxybenzoic acid; 3,4-diOH-benzoic acid: 3,4-dihydroxybenzoic acid; 3-OH-PAA: phenylacetic acid; 3,4-diOH-PAA:
3,4-dihydroxyphenylacetic acid; 3-OH-PPA: 3-(3-hydroxyphenyl)propionic acid, 4-OH-PPA: 3-(4-hydroxyphenyl)propionic acid; 3,4-diOH-PPA: 3-(3,4-
dihydroxyphenyl)propionic acid).
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diversity of polyphenols present in the wine/grape and tea extract
were funnelled through common degradation routes to a limited
number of metabolites that may be beneficial to the host. Each
individual generated a specific metabolite pattern, implying that
potential health effects may also vary among subjects. These
metabolite patternsmay be related to specific microbial composi-
tions. The identification of microbes involved in polyphenol
metabolism is challenging considering that several microbial
species may be involved in the production of one metabolite
due to metabolic cross-feeding mechanisms and/or common enzy-
matic properties shared by different microbial species. So far, only
some intestinal bacterial groups with polyphenol-metabolizing
capacities have already been identified, e.g. Eubacterium ramulus
and Clostridium orbiscindens (24, 41). Our study design was not
sufficiently powered to associate specific polyphenol metabolites
withmicrobial groupspresent in the initial fecal samples by taking
into account multivariate factors. Future studies on larger co-
horts may allow for exploring the link between the microbial
diversity and polyphenol metabolism. In this respect, function-
drivenmetagenomics seems to be a powerful approach to identify
functional anchors in complex microbial communities and may
increase the power due to the potential functional redundancy of
activities in the gut community (42, 43). Furthermore, in vitro
batch culture fermentations represent artificial conditions with
unknown validity in vivo. Future studies employing subject-
matched data analysis will be required to validate our findings
in vivo and to establish coherent links between in vitro bio-
conversion and in vivo bioavailability of polyphenols.
In conclusion, this study has unraveled individual micro-
bial bioconversion processes of complex polyphenol mix-
tures from black tea and red wine/grape and outlines the
extent of interindividual variability and differences due to
polyphenol sources. Importantly, the current findings de-
monstrate that metabolite profiles vary among individuals,
which may imply that corresponding health benefits depend-
ing onmicrobial bioconversion of dietary polyphenols cannot
be generalized. Furthermore, the results highlight key degra-
dation products and potentially interesting bioactive com-
pounds. Ultimately, this study is a first step toward a better
understanding of how dietary polyphenols may be involved in
beneficial health effects for the human body.
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Figure 5. Box plots depicting the concentrations of SCFAs (derived from 1H NMR spectra) after 72 h of fecal batch fermentation without polyphenols added
(indicated with blank) and with black tea (tea) and wine/grape (wine) polyphenols at a concentration of 1000 mg/L, respectively. Statistically significant
differences in the results of the polyphenol treatments compared to blank conditions are indicated with asterisks (** P < 0.01; * P < 0.05).
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